Smarter Decisions Begin with Better Data

  • Understand the impact of planned purchases on CMS and private payer reimbursement.
  • Consider indications for use, patient demographics, and comparative clinical effectiveness.
  • Anticipate any associated environmental factors needed to support the adoption of new devices and technology.
  • Evaluate features, functions, benefits, and total cost of ownership.
  • Measure and improve upon patient outcomes

Empowering healthcare providers with a step-by-step guide to making smarter decisions with better data for optimal financial and clinical impact.

The Strategic Role of Clinical Evidence in Value-Based Healthcare Capital Planning white paper will illustrate how introducing clinical evidence into the capital planning process can foster a more collaborative, strategic decision-making framework.


The white paper was written by:

  • Bill Donato, General Manager of MD Buyline, TractManager
  • Winifred Hayes, Founder of Hayes, Inc.

Download White Paper

open form